Blood Cell Count Derived Inflammatory Indexes in Acute Exacerbation of Idiopathic Pulmonary Fibrosis | MicrobiomeTrials← Back to trialsNCT07783230
Blood Cell Count Derived Inflammatory Indexes in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-09Est. Completion: 2027-09
Enrollment target: 70 participants Other microbiome trials you might be interested in
Interstitial Lung DiseaseChronic Obstructive Pulmonary DiseaseHypoxemia
Fibrotic forms of interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD) are chronic lung dise…
Buffalo, United StatesCompleted Oct 2027
Idiopathic Pulmonary Fibrosis
This is a randomized, placebo-controlled trial of metformin in 400 participants with idiopathic pulmonary fibrosis (IPF)…
Tucson, United StatesEst. completion Mar 15, 2029
Phase 2
Recruiting
Idiopathic Pulmonary Fibrosis (IPF)
Rationale: LTI-03 is an experimental medication breathed into the lungs using an inhaler. It is being studied for the tr…
Birmingham, United StatesEst. completion Sep 30, 2027